Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

The assessment of depression in people with multiple sclerosis: a systematic review of psychometric validation studies.

Hind D, Kaklamanou D, Beever D, Webster R, Lee E, Barkham M, Cooper C.

BMC Psychiatry. 2016 Aug 4;16:278. doi: 10.1186/s12888-016-0931-5.

2.

Diagnostic accuracy for major depression in multiple sclerosis using self-report questionnaires.

Fischer A, Fischer M, Nicholls RA, Lau S, Poettgen J, Patas K, Heesen C, Gold SM.

Brain Behav. 2015 Sep;5(9):e00365. doi: 10.1002/brb3.365. Epub 2015 Jul 14.

3.

Validation of mood measures for people with multiple sclerosis.

Watson TM, Ford E, Worthington E, Lincoln NB.

Int J MS Care. 2014 Summer;16(2):105-9. doi: 10.7224/1537-2073.2013-013.

4.

Preoperative predictors of pain following total knee arthroplasty.

Noiseux NO, Callaghan JJ, Clark CR, Zimmerman MB, Sluka KA, Rakel BA.

J Arthroplasty. 2014 Jul;29(7):1383-7. doi: 10.1016/j.arth.2014.01.034. Epub 2014 Feb 7.

5.

Evidence-based guideline: assessment and management of psychiatric disorders in individuals with MS: report of the Guideline Development Subcommittee of the American Academy of Neurology.

Minden SL, Feinstein A, Kalb RC, Miller D, Mohr DC, Patten SB, Bever C Jr, Schiffer RB, Gronseth GS, Narayanaswami P; Guideline Development Subcommittee of the American Academy of Neurology..

Neurology. 2014 Jan 14;82(2):174-81. doi: 10.1212/WNL.0000000000000013. Epub 2013 Dec 27.

6.

Emotional change-associated T cell mobilization at the early stage of a mouse model of multiple sclerosis.

Piras G, Rattazzi L, McDermott A, Deacon R, D'Acquisto F.

Front Immunol. 2013 Nov 21;4:400. doi: 10.3389/fimmu.2013.00400. eCollection 2013.

7.

Predictors of postoperative movement and resting pain following total knee replacement.

Rakel BA, Blodgett NP, Bridget Zimmerman M, Logsden-Sackett N, Clark C, Noiseux N, Callaghan J, Herr K, Geasland K, Yang X, Sluka KA.

Pain. 2012 Nov;153(11):2192-203. doi: 10.1016/j.pain.2012.06.021. Epub 2012 Jul 25.

8.

Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice.

de Sa JC, Airas L, Bartholome E, Grigoriadis N, Mattle H, Oreja-Guevara C, O'Riordan J, Sellebjerg F, Stankoff B, Vass K, Walczak A, Wiendl H, Kieseier BC.

Ther Adv Neurol Disord. 2011 May;4(3):139-68. doi: 10.1177/1756285611403646.

9.

Smaller cornu ammonis 2-3/dentate gyrus volumes and elevated cortisol in multiple sclerosis patients with depressive symptoms.

Gold SM, Kern KC, O'Connor MF, Montag MJ, Kim A, Yoo YS, Giesser BS, Sicotte NL.

Biol Psychiatry. 2010 Sep 15;68(6):553-9. doi: 10.1016/j.biopsych.2010.04.025. Epub 2010 Jun 19.

10.

Increased plasma homocysteine levels in patients with multiple sclerosis and depression.

Triantafyllou N, Evangelopoulos ME, Kimiskidis VK, Kararizou E, Boufidou F, Fountoulakis KN, Siamouli M, Nikolaou C, Sfagos C, Vlaikidis N, Vassilopoulos D.

Ann Gen Psychiatry. 2008 Sep 9;7:17. doi: 10.1186/1744-859X-7-17.

11.

A population-based study of depressive symptoms in multiple sclerosis in Stockholm county: association with functioning and sense of coherence.

Gottberg K, Einarsson U, Fredrikson S, von Koch L, Holmqvist LW.

J Neurol Neurosurg Psychiatry. 2007 Jan;78(1):60-5. Epub 2006 Jul 17.

Supplemental Content

Support Center